🦊/Companies

LambdaVision Incorporated

Founded 2018 · 13 employees on LinkedIn · 6 known investors

Find your way into LambdaVision Incorporated

302 people in our graph share verified history with the LambdaVision Incorporated team — schools, employers, funds. One of them is your warm intro.

Amanda Dawsonunlockedknows Nicole L. Wagner · together at Florida State University (overlapped)
×5knows the team · via University of Connecticut
×6knows the team · via Florida State University

LambdaVision develops a protein-based artificial retina designed to restore vision for patients blinded by advanced retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration. The implant uses proteins similar to the visual pigment rhodopsin to mimic the light-absorbing function of damaged photoreceptor cells, and its manufacturing leverages space-based production.

Founders & leadership

LambdaVision Incorporated was founded in 2018 by Robert R. Birge.

RR
Robert R. BirgeFounder
NLNicole L. Wagner
Nicole L. WagnerinPresident and Chief Executive OfficerNicole Wagner holds a Ph.D. in molecular and cell biology from the University of Connecticut, with graduate research focused on optimizing light-activated proteins for device applications. She is co-founder, president, and CEO of LambdaVision, a biotechnology company developing a protein-based artificial retina manufactured using space-based production to restore vision in patients with retinal degenerative diseases.
JAJordan A. Greco
Jordan A. GrecoinChief Scientific OfficerJordan Greco holds a Ph.D. in Physical Chemistry from the University of Connecticut, where he studied photoactive proteins and their applications in biomimetic devices under Robert Birge. As Chief Scientific Officer of LambdaVision, he leads the development and manufacturing of the company's protein-based artificial retina, with responsibility for production techniques, quality assurance, and commercialization.

Investors · 6

Competitors · 1

by search overlap

Companies competing with LambdaVision Incorporated for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 7 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
NASAPhase I2023$156.5K
NASAPhase I2023$150K
NASAPhase II2020$749.5K
NASAPhase I2019$121.6K
National Science FoundationPhase II2016$742.2K
National Science FoundationPhase I2015$149.9K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2014$190.5K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does LambdaVision Incorporated do?
LambdaVision develops a protein-based artificial retina designed to restore vision for patients blinded by advanced retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration. The implant uses proteins similar to the visual pigment rhodopsin to mimic the light-absorbing function of damaged photoreceptor cells, and its manufacturing leverages space-based production.
Who founded LambdaVision Incorporated?
LambdaVision Incorporated was founded by Robert R. Birge in 2018.
Who are LambdaVision Incorporated's investors?
LambdaVision Incorporated's investors include Aurelia Foundry, Connecticut Innovations, Seraphim Space, Seven Seven Six, Band of Angels, E2MC Ventures.